Literature DB >> 25935168

Severe dyspnoea in a patient with chronic myelogenous leukaemia on a tyrosine kinase inhibitor.

Celalettin Ustun1, Nicole Randall1, Eitan Podgaetz2, Khalid Amin3, H Erhan Dincer4.   

Abstract

Entities:  

Keywords:  Drug induced Lung Disease; Pleural Disease

Mesh：

Substances：

Year:  2015        PMID： 25935168     DOI： 10.1136/thoraxjnl-2015-206841

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  3 in total

1.  Tyrosine Kinase Inhibitor-associated Fibrothorax.

Authors:  Andres M Adrianza; Carlos A Jimenez; Grecia L Aldana; Leonardo Pozo; Jorge E Cortes; Ala Eddin S Sagar
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405

2.  Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase.

Authors:  Julien Mahé; Emilie Patras de Campaigno; Anne-Laure Chené; Jean-Louis Montastruc; Fabien Despas; Pascale Jolliet
Journal:  Br J Clin Pharmacol       Date:  2018-08-05       Impact factor: 4.335

Review 3.  Dasatinib-induced pulmonary arterial hypertension.

Authors:  Nurgül Özgür Yurttaş; Ahmet Emre Eşkazan
Journal:  Br J Clin Pharmacol       Date:  2018-03-06       Impact factor: 4.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.